BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Coeliac Disease Autoimmunity: Real-World Data from Mass Vaccination Campaign

Background: Data on COVID-19 vaccine effectiveness among patients with coeliac disease are currently lacking because patients with immune conditions were excluded from clinical trials. We used our coeliac disease autoimmunity (CDA) cohort to explore the effectiveness of the BNT162b2 mRNA COVID-19 va...

Descripción completa

Detalles Bibliográficos
Autores principales: Ben-Tov, Amir, Lebwohl, Benjamin, Banon, Tamar, Chodick, Gabriel, Kariv, Revital, Assa, Amit, Gazit, Sivan, Patalon, Tal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534420/
https://www.ncbi.nlm.nih.gov/pubmed/37766374
http://dx.doi.org/10.3390/v15091968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534420/
https://www.ncbi.nlm.nih.gov/pubmed/37766374
http://dx.doi.org/10.3390/v15091968

Ejemplares similares